About Envigo
Envigo is a company based in Huntingdon (United Kingdom) founded in 2015 was acquired by Inotiv in November 2021. The company has 2 employees as of April 05, 2024. Envigo offers products and services including Toxicology Services, Histology Services, Research Models, and DMPK Services. Envigo operates in a competitive market with competitors including Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others.
- Headquarter Huntingdon, United Kingdom
- Employees 2 as on 05 Apr, 2024
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Envigo Research Private Limited
- Date of Incorporation 05 Apr, 2013
- Jurisdiction Ahmedabad, Gujarat, India
-
Annual Revenue
$678.52 K (USD)-41.6as on Mar 31, 2018
-
Net Profit
-$1.51 M (USD)-1367.73as on Mar 31, 2018
-
EBITDA
-$1.43 M (USD)-1115.85as on Mar 31, 2018
-
Latest Funding Round
$1.71 M (USD), Grant
Jan 01, 2016
-
Investors
European Union
& 2 more
-
Employee Count
2
as on Apr 05, 2024
- Acquired by
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Envigo
Envigo offers a comprehensive portfolio of products and services, including Toxicology Services, Histology Services, Research Models, and DMPK Services.
Conducts studies to evaluate drug and chemical safety risks.
Processes tissues for analysis in nonclinical development.
Supplies genetically engineered models for scientific studies.
Analyzes drug metabolism and pharmacokinetics in vivo.
People of Envigo
Unlock access to complete
Unlock access to complete
Leadership Team
30 people
Sales and Marketing
26 people
Software Development Team
23 people
Finance and Accounting
10 people
Operations Team
10 people
Senior Team
5 people
Human Resources and Administration
4 people
Legal and Compliance
4 people
Unlock access to complete
Funding Insights of Envigo
Investors in Envigo
Envigo has secured backing from 3 investors, including institutional investors. Prominent investors backing the company include European Union, Inotiv Co and AnaPath.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Locked | Locked | Locked | |
|
Clinical development and regulatory services are provided by Inotiv.
|
Locked | Locked | Locked | |
|
Specializes in histopathology, toxicology, and molecular pathology services for clients.
|
Locked | Locked | Locked |
Investor details for Envigo
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Envigo
Investment portfolio details for Envigo
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Envigo
Detailed financials for Envigo
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Envigo Comparisons
Peer comparison for Envigo
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Envigo
Envigo operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Charles River Laboratories, LabCorp, Cytel, Precision Medicine Group and Veeda Clinical Research, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Provider of drug discovery and preclinical development services
|
|
| Locked | Locked | Locked |
Provider of laboratory tests for physicians
|
|
| Locked | Locked | Locked |
Data analysis and statistical solutions are provided for life sciences.
|
|
| Locked | Locked | Locked |
Provider of clinical research, development, and commercialization services for life sciences
|
|
| Locked | Locked | Locked |
Drug development services encompassing clinical trials, bioanalytical support, and real-world evidence in healthcare.
|
|
| Locked | Locked | Locked |
Company offering specialised R&D and clinical development services for the development of precision medicine based drugs and devices
|
Detailed competitors of Envigo
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Envigo
Complete news archive for Envigo
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Envigo
Envigo was founded in 2015 and raised its 1st funding round 1 year after it was founded.
Envigo is headquartered in Huntingdon, United Kingdom.
As of Apr 05, 2024, the latest employee count at Envigo is 2.
Annual revenue of Envigo is $678.52K as on Mar 31, 2018.
Provider of drug discovery and development services using research models. It offers a full spectrum of services, from discovery and translational sciences to safety assessment and toxicology. These services encompass disease pharmacology (in vitro and in vivo), drug metabolism and pharmacokinetics (DMPK), bioanalysis, and cell and molecular biology. The company also provides research models and related services, including genetically engineered models, contract breeding, and surgical services. Support services include specialized histology and pathology, chemical services, and diet and bedding for research animals. Consulting services are available in areas such as DMPK data analysis and biomarker analysis.
Envigo's top competitors include LabCorp, Charles River Laboratories and Cytel.
Envigo offers Toxicology Services, Histology Services, Research Models, and DMPK Services.
Envigo has 3 investors. Key investors include European Union, Inotiv Co, and AnaPath.